3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
13
cyclopia sequence
7
Neoplasms
6
Multiple Myeloma
6
Fatigue
6
Neoplasms, Plasma Cell
5
Neoplasm Metastasis
4
Lung Neoplasms
4
Dyspnea
4
Carcinoma, Non-Small-Cell Lung
4
Anxiety Disorders
4
Uterine Cervical Neoplasms
3
Tobacco Use Cessation
3
Prostatic Neoplasms
3
Primary Myelofibrosis
3
Leukemia
3
Head and Neck Neoplasms
3
Depression
3
Carcinoma, Renal Cell
3
Vomiting
2
Smoking Cessation
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Parasomnias
2
Pancreatic Neoplasms
2
Pain
2
Osteosarcoma
2
Kidney Neoplasms
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Interventions
pembrolizumab
3
Axitinib
2
regorafenib
1
avelumab
1
amivantamab
1
Tretinoin
1
Specimen Handling
1
Radiation
1
Pemetrexed
1
Nelfinavir
1
Magnetic Resonance Spectroscopy
1
Glutamate Carboxypeptidase II
1
GSK-3326595
1
Etoposide
1
Endoscopic Mucosal Resection
1
Doxorubicin
1
Cisplatin
1
Bortezomib
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Adenoid Cystic
×
Surveys and Questionnaires
×
Clear all
No trials found.